A comparative study of Moducren and Moduretic and their effect on plasma potassium in essential hypertension.
D000328:Adult; D000368:Aged; D000584:Amiloride / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001835:Body Weight; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood*; D011412:Propanolamines / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D011897:Random Allocation; D013999:Timolol / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004338:Drug Combinations; D011412:Propanolamines; D011719:Pyrazines; D006852:Hydrochlorothiazide; C010247:amiloride, hydrochlorothiazide drug combination; C034428:moducrin; D000584:Amiloride; D013999:Timolol; D011188:Potassium